HYLENEX Recombinant (Halozyme, Inc.)
Welcome to the PulseAid listing for the HYLENEX Recombinant drug offered from Halozyme, Inc.. This Endoglycosidase [EPC],Glycoside Hydrolases [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Halozyme, Inc. |
NON-PROPRIETARY NAME: | Hyaluronidase (Human Recombinant) |
SUBSTANCE NAME: | HYALURONIDASE (HUMAN RECOMBINANT) |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Endoglycosidase [EPC],Glycoside Hydrolases [Chemical/Ingredient] |
ROUTE: | SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2005-12-02 |
END MARKETING DATE: | 0000-00-00 |
HYLENEX Recombinant HUMAN PRESCRIPTION DRUG Details:
Item Description | HYLENEX Recombinant from Halozyme, Inc. |
LABELER NAME: | Halozyme, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 150([USP’U]/mL) |
START MARKETING DATE: | 2005-12-02 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 18657-117_308df247-a446-4284-8a1a-04410cd25e52 |
PRODUCT NDC: | 18657-117 |
APPLICATION NUMBER: | NDA021859 |
Other HYALURONIDASE (HUMAN RECOMBINANT) Pharmaceutical Manufacturers / Labelers: